Randomized Controlled Trials in Hereditary Cancer Syndromes.

Abstract excerpt

Conducting randomized controlled trials (RCTs) in patients with germline mutations in genes that predispose to adult-onset cancer is hampered by the rarity of these mutations, barriers to their identification, and challenges inherent to randomizing high-risk individuals as part of a clinical trial. Most of the clinically relevant RCTs have been conducted in 3 syndromes in only some of the high-risk genes for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Neoplastic Syndromes, Hereditary
• Share to Adenomatous Polyposis Coli